Regulus Therapeutics Inc.
Q4 2024 13F Holders
Symbol
RGLS
CUSIP
75915K309
Type
Equity
Class
COM
Num filings
72
Total reported value, excl. options
$84.5 M
Compare 2024 Q4 to
2025 Q1
2024 Q3
2024 Q2
2024 Q1
2023 Q4
2023 Q3
2023 Q2
2023 Q1
2022 Q4
2022 Q3
2022 Q2
Manager
Report Date
Value ($000)
Shares
Option Type